The efficacy and safety of liraglutide adjunct to insulin treatment in type 1 diabetes

Update Il y a 4 ans
Reference: U1111-1138-0619

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To confirm superiority of liraglutide compared to placebo, both adjunct to insulin treatment, on glycaemic control, after 26 weeks of treatment in subjects with established type 1 diabetes in inadequate glycaemic control.


Inclusion criteria

  • Diabetes Mellitus, Type 1